Brady Johnson - 21 Mar 2022 Form 4 Insider Report for Cidara Therapeutics, Inc. (CDTX)

Role
Vice President, Finance
Signature
/s/ Brady Johnson
Issuer symbol
CDTX
Transactions as of
21 Mar 2022
Net transactions value
-$530
Form type
4
Filing time
23 Mar 2022, 18:11:11 UTC
Previous filing
11 Mar 2022
Next filing
04 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDTX Common Stock Sale $530 -654 -1.3% $0.8100 49,366 21 Mar 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.